Next Article in Journal
What Do We Know about Transcranial Direct Current Stimulation for Major Depression?
Next Article in Special Issue
The Increased Densities, But Different Distributions, of Both C3 and S100A10 Immunopositive Astrocyte-Like Cells in Alzheimer’s Disease Brains Suggest Possible Roles for Both A1 and A2 Astrocytes in the Disease Pathogenesis
Previous Article in Journal
Effects of Neuromuscular Electrical Stimulation (NMES) Plus Upper Cervical Spine Mobilization on Forward Head Posture and Swallowing Function in Stroke Patients with Dysphagia
Previous Article in Special Issue
Pathophysiological Mechanisms of Cognitive Impairment and Neurodegeneration by Toxoplasma gondii Infection
 
 
Review
Peer-Review Record

The Neuropathological Diagnosis of Alzheimer’s Disease—The Challenges of Pathological Mimics and Concomitant Pathology

Brain Sci. 2020, 10(8), 479; https://doi.org/10.3390/brainsci10080479
by Andrew King 1,2,*, Istvan Bodi 1,2 and Claire Troakes 2,3
Reviewer 1: Anonymous
Reviewer 2:
Reviewer 3: Anonymous
Reviewer 4: Anonymous
Brain Sci. 2020, 10(8), 479; https://doi.org/10.3390/brainsci10080479
Submission received: 25 June 2020 / Revised: 14 July 2020 / Accepted: 17 July 2020 / Published: 24 July 2020
(This article belongs to the Special Issue Neuropathology of Alzheimer’s Disease)

Round 1

Reviewer 1 Report

In the Review titled “The Neuropathological Diagnosis of Alzheimer’s 2 Disease – The Challenges of Pathological Mimics and 3 Concomitant Pathology” the authors describe current diagnostic methods to identify Alzheimer’s Disease (AD) patients and other concomitant pathologies with the aim of evaluating the effect of each pathology and how they affect the final clinical diagnosis.

The present review is very interesting because, currently, it is very difficult to discriminate the different pathologies with dementia because there are many pathologies that mimics the same symptoms. It is relevant for clinicians and also for researchers, since conducting a clinical trial requires an accurate patient diagnosis to be successful. 

In my opinion, only minor revision should be done:

  • Typo in legend of Figure 7: “d)” should be changed by b)
  • Typo in title of Table 4: “TDD-43” should be corrected to TDP-43
  • Legend of Figure 8: panel c) is missing in the legend.
  • Table 5 needs to be better explained because it is not clear the meaning of each “-“ and “+”.

Author Response

Please see the  attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

The paper is well written and organized. It is an up-to-date, comprehensive review of the literature in the field of AD neuropathology. The "Practical Considerations" comments for each individual chapters are intriguing  and innovative. 

Critical points:

1) in many part it has a neuropathology textbook profile.

2) it lacks of criticism. At the end, it should be noted that immunohistochemistry although relevant for understanding the molecular mechanisms of neurodegeneration process has not improved AD diagnosis. 

3) it is unclear to me whether the data reported in Fig.s 1, 3, 4, 5, 6, 7, and 8 are original or  other studies.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 3 Report

The article highlights the increasing difficulty in the histotopathological diagnosis of neurodegenerative diseases as well as the importance of immunohistochemical markers against specific proteins involved in these diseases. This is a thorough, well-documented review.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 4 Report

This review is extremely well written...the topics are interesting, pragmatic and potentially impactful. The organization is clear and logical.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Round 2

Reviewer 2 Report

All points have been taken into consideration.
In the current form the paper has improved slightly

Back to TopTop